Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Bovine-Derived Supplement, BSE Actions Under Congressional Scrutiny

This article was originally published in The Tan Sheet

Executive Summary

Two senior House Democrats seek FDA information on its efforts to track and control bovine-derived dietary supplement products that may be susceptible to potential BSE contamination in a Jan. 31 letter to Acting Commissioner Bernard Schwetz, PhD.

You may also be interested in...



Supplement AER Monitoring System Funding Request Lowered For FY 2002

Upgrades to FDA's dietary supplement adverse event monitoring system would be financed with $1 mil. in funding under the Bush Administration's fiscal year 2002 budget proposal.

Supplement AER Monitoring System Funding Request Lowered For FY 2002

Upgrades to FDA's dietary supplement adverse event monitoring system would be financed with $1 mil. in funding under the Bush Administration's fiscal year 2002 budget proposal.

Supplement AER Monitoring System Funding Request Lowered For FY 2002

Upgrades to FDA's dietary supplement adverse event monitoring system would be financed with $1 mil. in funding under the Bush Administration's fiscal year 2002 budget proposal.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092149

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel